Medical Condition News

RSS

Researchers compare clinical outcome of patients with smaller and larger AAAs after EVAR

Patients with abdominal aortic aneurysms of less than 5.5 cm have no significant differences in clinical outcomes after endovascular repair than those with larger AAAs according to data from a five-year prospective clinical trial setting. The researchers maintain their recommendation that small aneurysms should not be treated surgically.

8 Jun 2010

New study assesses accuracy of indirect estimated radiation doses during eTAAA

A new study, presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery® today, assessed the accuracy of indirect estimated radiation doses of 47 patients during endovascular thoracoabdominal aneurysm repair (eTAAA).

8 Jun 2010

TMI announces development of new clinical imaging system

With the results of the clinical trial at Duke University Medical Center completed, and the pending publication of the results, TMI is pleased to announce the development of their new clinical imaging system.

8 Jun 2010

Gene variant linked to ability of Tibetans to cope with low-oxygen conditions identified

A new study pinpoints the genetic changes that enable Tibetans to thrive at altitudes where others get sick.

8 Jun 2010

Sleep extension helps athletes achieve optimal performance: Research

Getting extra sleep over an extended period of time improves athletic performance, alertness and mood, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.

8 Jun 2010

Augmentation with Wright's GRAFTJACKET Matrix improves repair healing for large rotator cuff tears

Wright Medical Group, Inc., a global orthopaedic medical device company, announced today that results of a prospective, randomized controlled clinical study evaluating biologic augmentation of challenging arthroscopic rotator cuff repairs with GRAFTJACKET® Matrix were presented by F. Alan Barber, MD at the recent Arthroscopy Association of North America (AANA) annual meeting.

8 Jun 2010

Scientists combine two agents to treat patients with multiple myeloma

Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented data showing that by combining two treatment agents in the care of multiple myeloma patients, doctors can use higher dosages of chemotherapy before autologous stem cell transplant while alleviating painful and debilitating side effects like severe oral mucositis (mouth ulcers).

8 Jun 2010

Secondhand smoke exposure associated with psychological distress

Exposure to secondhand smoke appears to be associated with psychological distress and the risk of future psychiatric hospitalization among healthy adults, according to a report posted online today that will appear in the August print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

8 Jun 2010

Regular exercise reduces fall risk

Remaining physically fit and sticking to a regular exercise routine could lower your risk of taking a tumble, finds a new research study.

8 Jun 2010

CXCR4 protein may aid restore damage from MS and other neurodegenerative diseases: Researchers

A protein that helps build the brain in infants and children may aid efforts to restore damage from multiple sclerosis and other neurodegenerative diseases, researchers at Washington University School of Medicine in St. Louis have found.

8 Jun 2010

Findings from Abraxis BioScience's phase 3 ABRAXANE trial in patients with NSCLC presented at ASCO

Abraxis BioScience, Inc. announced today that findings from their phase 3 randomized trial of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) plus carboplatin, showed a statistically significant 31 percent improvement in overall response rate when compared with Taxol (paclitaxel) injection plus carboplatin in the first-line treatment of patients with non-small cell lung cancer.

8 Jun 2010

Chemotherapy drug sunitinib promising for HIV-positive cancer patients

Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).

8 Jun 2010

Nurses working 12-hour shifts struggle to remain vigilant during successive shifts: Research

A small percentage of nurses struggle to remain vigilant during successive 12-hour shifts, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.

8 Jun 2010

$Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL$

Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL

Hana Biosciences Inc.,, today announced complete data from its pivotal, Phase 2 RALLY clinical trial for Marqibo® (vincristine sulfate liposome injection) for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). Results from the RALLY trial demonstrated compelling evidence of single-agent, anti-leukemic activity in an advanced, heavily pre-treated, adult ALL population.

8 Jun 2010

Low LDL cholesterol levels increase life expectancy

A University of Minnesota study definitively shows that those with decreased LDL cholesterol levels can count on an increased life expectancy. The research is published in the May 24 edition of the Annals of Surgery.

8 Jun 2010

Polaris' ADI-PEG 20 novel anticancer drug inhibits growth of metastatic melanoma cells: Study

Physicians attending the annual meeting of the American Society of Clinical Oncology (ASCO) presented evidence that pegylated arginine deiminase (ADI-PEG 20), a novel anticancer drug that targets ASS(-) tumors, and which is being developed and manufactured by Polaris Group, was effective in inhibiting the growth of metastatic melanoma cells.

8 Jun 2010

Day shifts allow workers to get more sleep than night shifts: Study

Regulations that limit the number of hours worked also should provide guidance for shift start times to maximize workers' sleep opportunity and minimize the risk of on-the-job fatigue, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.

8 Jun 2010

Combat in Iraq associated with post-deployment PTSD, depression in 8.5 to 14% of soldiers

Between 8.5 percent and 14 percent of soldiers returning from Iraq report serious functional impairment due to either posttraumatic stress disorder or depression, according to a report in the June issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

8 Jun 2010

Children and teens with moderate to severe OSA have lower academic grades: Research

The average academic grades of children and teens with moderate to severe obstructive sleep apnea are worse than the grades of students who have no sleep-disordered breathing, according to a research abstract that will be presented Tuesday, June 8, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC.

8 Jun 2010

Research findings open door to development of new therapies for lymphomas, leukemias

Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.

8 Jun 2010

Medical Condition News

Researchers compare clinical outcome of patients with smaller and larger AAAs after EVAR

New study assesses accuracy of indirect estimated radiation doses during eTAAA

TMI announces development of new clinical imaging system

Gene variant linked to ability of Tibetans to cope with low-oxygen conditions identified

Sleep extension helps athletes achieve optimal performance: Research

Augmentation with Wright's GRAFTJACKET Matrix improves repair healing for large rotator cuff tears

Scientists combine two agents to treat patients with multiple myeloma

Secondhand smoke exposure associated with psychological distress

Regular exercise reduces fall risk

CXCR4 protein may aid restore damage from MS and other neurodegenerative diseases: Researchers

Findings from Abraxis BioScience's phase 3 ABRAXANE trial in patients with NSCLC presented at ASCO

Chemotherapy drug sunitinib promising for HIV-positive cancer patients

Nurses working 12-hour shifts struggle to remain vigilant during successive shifts: Research

Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL

Low LDL cholesterol levels increase life expectancy

Polaris' ADI-PEG 20 novel anticancer drug inhibits growth of metastatic melanoma cells: Study

Day shifts allow workers to get more sleep than night shifts: Study

Combat in Iraq associated with post-deployment PTSD, depression in 8.5 to 14% of soldiers

Children and teens with moderate to severe OSA have lower academic grades: Research

Research findings open door to development of new therapies for lymphomas, leukemias

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News